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Abstract
A good, understandable informed consent form (ICF) is key to ethical medical research, and the
ICF is necessary according to United States federal regulation. Since they may be written in
complex technical language, ICFs are often difficult for subjects to understand. The purpose of
this research was to evaluate students' understanding of terminology commonly used in the ICF.
An online research survey was sent to active students of Eastern Michigan University (EMU)
during the winter 2015 semester. Questions were asked to evaluate the students' understanding of
the correct meaning of the terms used in medical research. The majority of students understood
common terminology used in informed consents, but they were confused about the meaning of
the term "Clinical Research/Trial" and the location where the clinical studies were conducted.
Therefore, investigators and Institutional Review Boards (IRBs) need to be aware of these
potentially confusing items when writing an ICF.
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Introduction
The American Medical Association defines informed consent as the ‘‘process of
communication between a patient and physician that results in the patient’s authorization or
agreement to undergo a specific medical intervention,” (as cited in Alonso, Alejandro, & Emma,
2013, p. 2). Informed consent has a long history. From the traditional vivisection of condemned
men, to the scandalous U.S. Public Health Service Syphilis Study at Tuskegee and the Nazi
experimentation on huge numbers of prisoners during World War II, patients have not always
known they were being utilized as test subjects (as cited in Dresden & Levitt, 2001). Informed
consent of research subjects was first stated as a research standard in 1947 in the Nuremberg
Code and later in the Declaration of Helsinki (1964) and the Belmont Report (1978) (as cited in
Dresden & Levitt, 2001). In recent decades, there has been far-reaching recognition of the
significance of educated assent in medicine and in research (Dawson & Kass, 2005). Lack of
obtaining proper informed consent affects patient autonomy (Lo, 2000). Patient autonomy is very
important in ethical medical practices. A human subject must have the opportunity to choose
what ought to or ought not happen to his/her body, making a decision based on relevant data. No
third party may force a patient to act in a specific way. Indeed, even though the physician can
assist the subject’s decision making, all the decisions must be made by subject. A good,
understandable informed consent form (ICF) is key to ethical medical research and, as such,
ICFs are required by US federal regulation.
Respect for persons is an important principle of the Belmont Report and is linked to
informed consent. As noted in the Belmont Report, "Respect for person incorporates at least two
ethical convictions: first, that individuals should be treated as autonomous agents and second that
persons with diminished capacity are entitled to protection" (as cited in Jonsen, 1999, p. 23).
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According to Applebaum, Lidz, and Meisel (1987), an understandable informed consent process
will aid in obtaining consent from subjects, which shows their voluntariness.
Many authors reported that the typical ICF is written at a reading level that needs a
minimum of a high school education or higher to understand (Baker & Taub, 1983; Gray, Cooke,
& Tannenbaum, 1978; Grossman, Piantadosi, & Covahey, 1994; Grunder, 1980;
Hammerschmidt & Keane, 1992; Mede & Howser, 1992; Morrow, 1980; Ogloff & Otto, 1991).
According to Grossman, Piantadosi, and Covahey (1994), the average person can read an ICF
written at the eighth grade reading level. However, some researchers reported that participants do
not fully understand the disclosure information provided in ICFs (Bergler, Pennington, Metcalfe,
& Freis, 1980; Joffe, Cook, Cleary, Clark, & Weeks, 2001; Miller, Searight, Grable, Schwartz,
Sowell, & Barbarash, 1994). Education plays an vital role in understanding and recall of the
information given at the time of informed consent procedure (Waggoner & Sherman, 1996;
Lawson & Adamson, 1995). ICFs are often difficult to understand since they are written with
complex technical language that is difficult for many patients to understand (Hopper, TenHave,
& Hartzel, 1995; Paasche-Orlow, Taylor, & Brancati 2003). Some authors reported that
participant understanding may be raised if the ICF is easy to read (Beardsley, Jefford, &
Mileshkin 2007; Bjorn, Rossel, & Holm, 1999; Paris, Chaves, Cornu, Maison, & Salvat-Mélis
2007; Taub, Baker, Kline, & Sturr 1987; Young, Hooker, & Freeberg 1990). Situations where
participants did not understand the ICF have provoked calls for investigators along with
institutional review boards (IRBs) to search for methods to advance research participants'
understanding of the ICF (Lavori, Sugarman, Hays, & Feussner 1999; Siminoff, 2003). Data
from various western countries, including the United States, showed that research subjects
regularly do not understand placebo treatment or randomization (Elbourne, Snowdon, & Garcia
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1997; Snowdon, Garcia, & Elbourne 1997), and deliberations to expand patient understanding of
research utilizing distinctive methodologies to informed consent have mixed results (Dunn,
Lindamer, Palmer, Schneiderman, & Jeste, 2001; Sorrell, 1991; Stiles, Poythress, Hall,
Falkenbach, & Williams, 2001). It is also interesting to note that simplified information, when
provided to patients, results in reduced anxiety about consent and increased understanding with
the ICF (Coyne, Xu, Raich, Plomer, & Dignan, 2003).
In this aspect, it is very important to know whether the terminology used in ICF is
understandable. Therefore, this study examined to what extent university students understand
terms often used in an ICF.
Purpose of the Study
The purpose of this research was to investigate college students' comprehension of terminology
commonly used in informed consent forms. Based on the results, suggestions were made to
researchers and Institutional Review Boards regarding Informed Consent terminology.
Research Questions
•

How well do college students understand the terms often used in Informed Consent
Forms?

•

Which sub-population of college students understands and which sub-population was not
able to understand the terminology used in ICF?

•

Does year in school or graduate student status affect the understanding of the terms used
in ICF among college students?
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Research Design and Methodology
An online research survey was sent to all active students of Eastern Michigan University
(EMU) in the winter 2015 semester by EMU's Office of Institutional Research and Information
Management (IRIM) using Qualtrics online survey software. A total of 20,006 students were
invited to participate in the survey. The research survey posed a series of questions related to
common terminology used in ICF. Demographic data were collected, including age range, sex,
ethinic group, class year and college major of the students. Correlation was examined between
these demographic characteristics and familiarlity with the terminology most commonly used in
the ICFs. The survey was distributed after receiving approval from the University Human
Subjects Review Committee (UHSRC) of EMU (Appendix A). The survey remained active
online for two weeks. A copy of the survey, including the online consent form, may be found in
Appendix B. The results were examined for any large (≥10%) incorrect responses. These
responses were then examined by cross tabulation with demographic data. Any possible
relationship with demographic data was examined using appropriate statistical tests.
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Results
The survey was sent to 20,006 students, of which 1,899 (10.70%) participated in the
study. However, only 1,869 (10.53%) provided answers to the survey questions. The data used
in this study were extracted from the participants who answered survey questions. The other
respondents were excluded from all analysis, including demographics. The response rate appears
typical for a survey of this type. Demographic results are presented in Table 1.
Table 1
Demographic description of the respondents
Percent
Response Rate

Age

Sex
Ethnic Group

College year

College Major
or Program

Valid
Missing
Total
18-24
25-34
35 or Older
Female
Male
White
Black or African-American
Native Hawaiian or other
Pacific Islander
Asian
American Indian or Alaska
Native
Other/ multi-ethnic
First year
Second Year
Third Year
Fourth Year or beyond
Graduate Student
Arts & Science
Business
Education
Health & Human Services
Technology
Others

1869
30
1899
1109
430
330
1291
578
1408
202
3

10.7%
59.3%
23.0%
17.7%
69.1%
30.9%
75.5%
10.8%
0.2%

108
6

5.8%
0.3%

137
283
208
318
548
504
665
238
280
457
171
57

7.3%
15.2%
11.2%
17.1%
29.4%
27.1%
35.6%
12.7%
15.0%
24.5%
9.2%
3.1%
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Ten questions were chosen to evaluate the students' understanding of the correct meaning of
terms commonly used in medical research. However, only eight questions were included in the
survey due to an error by the EMU Research group. As a result, questions 3 ("Randomization")
and 6 ("Reimbursement") in Appendix B were not included in the survey, and no results are
available. The number of correct responses to the eight survey terms are presented in Tables 2
and 3. The terms "placebo," "biopsy," and "consent" were understood by >90% of the
respondents, and no further analysie were conducted for these terms.
Table 2
Comparisons of responses by the participants to various questions
1
2
Clinical
Placebo
Research
Correctly
797
1639
answered
(45.1 %)
(92.7%)
See Appendix B for the options offered.

3
Biopsy

4
Consent

1682
(95.2%)

1627
(92.1%)

5
Clinical
investigator
1319
(74.7%)

6
Efficacy
1273
(72.1%)

When the question on "Clinical research” or “Clinical trial" was asked, 797 participants
(45.1 %) responded correctly (i.e., Scientific investigations using humans to study treatment of
human disease), but 80 participants (4.5%) said they were 'not sure' what the term means. While
71 participants (4.0%) chose Scientific investigations using animals to study treatment of human
disease, 819 participants (46.6%) chose Scientific investigations using laboratory studies to
study treatment of human disease. Cross tabulations were examined for this question. The only
answer that showed any relationship to a demographic variable was the term "clinical research/
trial" by class year. Figure 1 presents the percent answering correctly for "clinical research/trial"
by class year.
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Percentage of Correct Answers
Percentage of Correct Answers

60.00%
50.00%
40.00%
30.00%
20.00%
10.00%
0.00%
First year

Second year

Third year

Fourth year or Graduate Student
beyond

College population by class year

Figure 1. “Clinical Research/Trials” answers by class year

Using the Cochran-Armitage Trend Test (Agresti, 2002), the increasing trend of correct answers
was tested for statistical significance. The results of the Cochran-Armitage Trend Test yielded a
Z Statistic of 4.6463. The corresponding p-value is < .0001, rejecting the null hypothesis of no
difference and accepting the alternative hypothesis that there is a statistically significant
increasing trend in the population proportions.
When asked to define the term "placebo", 1639 participants (92.7%) gave the correct
answer, 73 participants (4.1%) said they were not sure what is meant by “placebo” while the rest
(3.2%) chose incorrectly. When the meaning of "biopsy" was asked, 1682 participants (95.2%)
participants chose the correct answer, and 61 participants (3.5%) said they were not sure, while
the remaining (1.3%) chose wrong answers. When the meaning of the term "consent" was asked,
1627 participants (92.1%) chose the correct answer, while 17 participants (1.0%) said they were
not sure of the meaning of the term, and the rest (6.9%) chose wrong answers. When asked about
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the meaning of the term "clinical investigator", 1319 participants (74.7%) responded correctly
(i.e., Someone in charge of carrying out a research study in a hospital), while 172 participants
(9.7%) said they were 'not sure' of the term. Additionally, 88 participants (5.0%) chose Someone
who finds criminal activities in hospitals, and 187 participants (10.6%) chose Someone who
works in a laboratory in a hospital. When asked about the word "Efficacy", 1273 participants
(72.1%) responded correctly (i.e., The ability of a drug to produce the desired effect), 346
participants (19.6%) said they were 'not sure' of what the term means, 72 participants (4.1%)
chose The ability of a drug to produce no adverse effects, and 75 participants (4.2%) chose The
ability of a drug to be used by the patient. No meaningful demographic differences were
observed when "placebo," "biopsy," "consent," "clinical investigator," or "efficacy" were
examined in cross-tabulations.
Table 3
Responses to the question "Where do you think clinical research studies are conducted?"
Hospitals
Where do
you think
clinical
research
studies are
conducted?

896 (47.2%)

University
Medical centers
1346 (70.9%)

Clinics
660 (34.8%)

Private Physician’s
office
302 (15.9%)

Not sure
87 (4.6%)

When the question "Where do you think clinical research studies are conducted?" was
asked, 896 participants (47.2%) chose “hospitals” while 1346 participants (70.9%) chose
“university medical centers,” 660 participants (34.8%) chose “clinics,” 302 participants (15.9%)
chose “private physician’s office,” and 87 participants (4.6%) said they were not sure about
where the clinical research studies were conducted (Table 3). Only 42.2 % correctly chose all 4
possible locations. When participants’ college majors or programs were considered, among all
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the partcipants, students in the College of Arts and Science chose the highest number of correct
answers (>30%) which included hospital (37.2%), university medical centers (36.3%), clinics
(35.3%) and private physician’s office (33.1%). No other college major answered this question
above 30%.
When the question "You must have the disease being studied to volunteer for a clinical
study?" was posed, 1168 participants (66.1%) correctly chose the answer "false", while 404
participants (22.9%) incorrectly chose "true", and 196 participants (11.1%) chose “Not sure.”
No significant demographic differences were observed for this question.
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Discussion
Understanding the terminology of informed consent used in research has a high value
since it determines the research subjects' understanding of research and their volunteering in
research participation. For seven out of eight questions posed to a college population, the
majority of the students understood the terms. For the term clinical research/trial, however, only
45.1% understood the meaning. Upon further examination, it was discovered that understanding
improved with educational level, yet still only 52.1% of graduate students understood the
meaning of the term “clinical research/trial.” Therefore, it is clear that the understanding of this
term was greater in more highly educated students in the survey population (graduate students).
Whether this increase by class year is due to increased formal education or simply age cannot be
determined by this survey. The understanding level is still low in graduate students as they were
confused the term "clinical research/trial" with "clinical laboratory."
This study was not conducted in a typical clinical research population; this population has
attained a higher educational level than that normally found in research study populations. Thus,
the results would likely be skewed towards more knowledgable respondants and correct
responses in a more typical population would likely be lower. Investigators should be aware of
the population used in a clinical study. Educational level has previously been shown to correlate
with a better understanding of terms used in informed consent (Waggoner & Sherman, 1996). As
participants’ age and/or level of education increased, the level of understanding of the term
"clinical research/trial" increased in college students, but this may not be true in the general
population as a clinical study population may not be as highly educated. The students responded
to "placebo," "biopsy," and "consent" with a high level of understanding (>90% correct). Fewer
students understood "clinical investigator" and "efficacy," but the results still showed a good
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understanding of these terms (>70% correct). The results of these questions showed no
relationship to any demographic variable.
In response to the statement "You must have the disease being studied to volunteer for a
clinical study," 66.1 % of participants chose "false." For the participation of Phase I clinical
trials, the volunteer may or may not have to have the disease. Phase I clinical studies are
conducted mostly on healthy volunteers to determine safety. College students often make up a
large percent of Phase I volunteers, and a large number of students (66.1 %) in the survey
understand that disease-free volunteers may participate in Phase I clinical trials.
By observing the overall findings, most of the terms used in the survey were understood
by the college students who participated. Graduate students only understood the term "clinical
research/trial" better than the undergraduate students. No demographic differences were
observed for the rest of the words tested. However, for question 7 concerning the location of
clinical students, students in the College of Arts and Science answered better than the rest,
although it is unlikely that this difference is meaningful. This means that regardless of age, sex,
ethnicity, college major, and college class, most of the questions were understood by the
majority of the students. Since the participants were college students, they would be considered
better educated than the general clinical research population. It is therefore recommended that
when the term “clinical research/trial” or similar terminology is used in patient recruitment
activities, the usage is quickly followed by an explanation that the study will be in patients or
volunteers. Otherwise, perspective participants may believe the activity is related to the clinical
laboratory. The potential for misunderstanding the other terms used in this survey in a more
typical clinical research population cannot be determined here, although investigators are
cautioned not to extrapolate these findings too broadly.
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Conclusion
Eight terms often used in clinical studies and in informed consent forms were tested for
comprehension by a college-aged population. Six terms were fairly well understood by this
population. The survey revealed, however, that this population did not accurately differeniate
the terms clinical research from clinical laboratory. The population also was generally not aware
of the diverse locations for clinical research. Researchers and Institutional Review Boards are
cautioned to keep these findings in mind when writing study recruitment or informed consent
documents, especially if the study population is less educated than this group of college students.
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Appendix A: Approval Letter from EMU Human Subject Review Committee
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Appendix B: Sample Survey Form*
Health Terminology Familiarity

Q1. Age Range:
18 - 24 years old
25 - 34 years old
35 - or older

Q2. Sex: Female ( )

Male ( )

Q3. In which ethnic group do you classify yourself?
1. White
2. Black or African-American
3. Native Hawaiian or other Pacific Islander
4. Asian
5. American Indian or Alaska Native
6. Other / multi-ethnic

Q4. What is your class year in college?
1. First year
2. Second year
3. Third year
4. Fourth year or beyond
5. Graduate
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Q5. In which college is your major or with which are you most closely associated?
1. Arts & Sciences
2. Business
3. Education
4. Health & Human Services
5. Technology
6. Others
Please choose the answer(s) that best represents your understanding of the meaning of each
term:*

Q1. Clinical research or clinical trials
1. Scientific investigations using humans to study treatment of human disease
2. Scientific investigations using animals to study treatment of human disease
3. Scientific investigations using laboratory studies to study treatment of human disease
4. Not Sure
Q2. Placebo
1. A method to test new drugs
2. An inactive or fake drug given in research
3. Any drug given in research
4. Not sure
Q3. Randomization
1. A type of health insurance
2. A method of assigning patients into study groups by the order of study enrollment
3. A method of assigning patients into study groups by chance
4. Not sure
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Q4. Biopsy
1. The removal of tissue, cells, or fluids from someone’s body to check for illness
2. It is a type of treatment given to improve side effects
3. It is a branch of psychology that analyzes behaviors, thoughts and feelings
4. Not sure
Q5. Consent
1. Agreement to enter a proposed study
2. Understanding a proposed study
3. Signing an explanation of a propsed study.
4. Not sure
Q6. Reimbursement
1. Method of paying fees to physician
2. Method of paying expenses to a patient
3. Insurance
4. Not sure
Q7. Clinical Investigator
1. Someone who finds criminal activities in hospitals
2. Someone in charge of carrying out a research study in a hospital
3. Someone who works in a laboratory in a hospital
4. Not sure
Q8. Efficacy
1. The ability of a drug to produce the desired effect
2. The ability of a drug to produce no adverse effects
3. The ability of a drug to be used by the patient
4. Not sure
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Q9. Where do you think clinical research studies are conducted?
1. Hospitals
2. University Medical Centers
3. Clinics
4. Private Physician's Office
5. Not sure
Q10. You must have the disease being studied to volunteer for a clinical study.
1. True
2. False
3. Not sure

*Correct answers in bold

